Post-maintenance therapies
In this session from Solving Kids’ Cancer UK's Neuroblastoma Parent Symposium 2025, Professor Juliet Gray explores the development of therapies given after frontline treatment for high-risk neuroblastoma to help reduce the risk of relapse. She discusses current approaches being investigated and the challenges of evaluating new treatments for children with no evidence of disease.
-
Need to speak to someone?Get in touch with our Family Support Team.
-
Help and supportHead to our Help and Support homepage to explore how we can support you.
-
Treatment for neuroblastomaRead more about the different types of treatment for neuroblastoma.
-
Maintenance therapiesLearn more about maintenance therapies after completing treatment for neuroblastoma.
Related videos
-
Video (2025)What is neuroblastoma?
Overview of neuroblastoma, including how the disease develops, its characteristics, diagnosis, risk classification, and standard treatment approaches.
-
Video (2026)Understanding current frontline treatment
Overview of how high-risk neuroblastoma is treated in the US and Europe, including current frontline approaches through COG and SIOPEN.
-
Video (2026)Finding trusted information
Explores how families can find trusted, evidence-based information about neuroblastoma, shares a parent's experience of reliable sources, and highlights the role of the National Neuroblastoma Advisory Panel.